Dermata Therapeutics(DRMA) - 2025 Q1 - Quarterly Results

FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2025 Dermata Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) Delaware 001-40739 86-3218736 (I.R.S. Employer Identification No.) (Address of principal executive offices) (Zip Code) (858) 800 ...